Data use registers are a key component of improving transparency and trust in the use of health data for research - they allow patients and members of the public to see and feel confident in how patient data is being requested.
The data use register for the UK Renal Registry is publicly available to view on the HDR Innovation Gateway.
To show that only qualified people in secure settings can access our data, and for purposes that benefit the public, the content and structure of individual data uses follows Five Safes Framework. The Five Safes framework is a set of principles which enable data services to provide safe research access to data. The framework originated from the ONS and was developed by them and other data providers in the 2010s. The framework has become best practice in data protection whilst fulfilling the demands of open science and transparency.
The register implements a national standard for data use registers, developed after wide consultation with data custodians and the public:
Macaulay, Y., UK Health Data Research Alliance, Pan-UK Data Governance Steering Group, HDR UK Public Advisory Board, & Five Safes Action Force. (2023). Pan-UK Data Governance Steering Group Data Access Transparency Standards. Zenodo. https://doi.org/10.5281/zenodo.8262453
International comparison of patient survival after start of renal replacement therapy in 12 countries in Europe
The changing trends and outcomes in the epidemiology of paediatric renal replacement therapy in Europe: data from the ESPN/ERA-EDTA Registry
Access to transplantation and transplant outcome measures (ATTOM)
The High-volume Haemodiafiltration vs High-flux Haemodialysis Registry Trial (H4RT)
UK Chinese population with kidney failure: patient characteristics and treatment modalities
Does case mix explain between-centre variation in comorbidity in paediatric patients?
Trends in excess mortality of adult patients on renal replacement therapy compared to the general population in Europe
Understanding the relationship between symptom burden and quality of life in chronic kidney disease: a UK cohort study in 3,325 patients
Patient survival in children treated with chronic renal replacement therapy – a global comparison between renal registries
Patient activation, symptom burden and quality of life in the TP-CKD cohort
Pagination
- Previous page
- Page 3
- Next page